Keyphrases
Oropharyngeal Squamous Cell Carcinoma (OPSCC)
100%
High-risk Human Papillomavirus (HR-HPV)
53%
Population-based Study
28%
Head-and-neck Cancer
24%
Danish Population
21%
Denmark
20%
Overall Survival
19%
Diagnostic Work-up
14%
Transoral
14%
National Cohort Study
14%
HPV Positive
14%
Meta-analysis
14%
Salivary Gland Cancer
14%
Systematic Meta-analysis
14%
Hazard Ratio
12%
HPV16
12%
Cancer Mortality
12%
Magnetic Resonance Imaging
11%
Diagnostic Accuracy
10%
Tumor
9%
Primary Radiotherapy
8%
HPV Negative
8%
Mortality Risk
8%
Transcervical
7%
Human Papillomavirus Genotypes
7%
High Prevalence
7%
Human Papillomavirus Testing
7%
Recurrence-free Survival
7%
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
7%
Prognostic Marker
7%
Oropharynx
7%
Multicenter Clinical Trial
7%
Non-aspirin Non-steroidal Anti-inflammatory Drugs
7%
Neutrophil-to-lymphocyte Ratio
7%
Outpatient Clinic
7%
P16INK4a
7%
Ultrasound
7%
Prognostic Implications
7%
Second Primary Cancer
7%
Individual Patient Data Analysis
7%
Epidemiological Trends
7%
Pediatric
7%
Distant Metastasis
7%
FDG Uptake
7%
Children with Cancer
7%
HPV Genotyping
7%
Older Adults
7%
Cervical Intraepithelial Neoplasia
7%
Low-dose Aspirin
7%
Aspirin Use
7%
Medicine and Dentistry
Oropharynx Squamous Cell Carcinoma
65%
Wart Virus
57%
Oropharyngeal Cancer
52%
Systematic Review
29%
Recurrent Disease
24%
Overall Survival
23%
P16
20%
Diagnosis
14%
Meta-Analysis
14%
Salivary Gland Cancer
14%
Human Papillomavirus Type 16
12%
Magnetic Resonance Imaging
11%
Clinical Trial
11%
Hazard Ratio
10%
Neoplasm
10%
Diagnostic Accuracy
10%
Radiation Therapy
9%
Malignant Neoplasm
9%
Prevalence
8%
Head and Neck Cancer
8%
Recurrence Free Survival
8%
Oropharynx Tumor
7%
Second Cancer
7%
Outpatient
7%
Neutrophil
7%
Lymphocyte
7%
Echography
7%
Patient-Data
7%
Pediatrics
7%
Distant Metastasis
7%
Epidemic
7%
Cervical Intraepithelial Neoplasia
7%
Pediatric Cancer
7%
Disease Free Survival
5%
